Form 483

Octapharma Plasma, Inc. Form 483, 2024-03-22

FDA issued a Form 483 to Octapharma Plasma, Inc. on 2024-03-22 with 1 public-safe observation.

483· Form 483 issuedBiologics1 observation

Octapharma Plasma, Inc. · Dallas, United States · Issued March 22, 2024

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

22 Mar 2024
21 CFR 606.60(a)

Provide proper equipment to meet requirements

Cited by Ramon L Gonzalez-Prieto

Inspected site

OPOctapharma Plasma, Inc.Dallas, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 606.60(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 1 observation

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere